A peptide nucleic acid-based pretargeting approach using <sup>161</sup>Tb for radionuclide therapy in a murine tumor model. [PDF]
Li H +9 more
europepmc +1 more source
Editorial: Women in radionuclide therapy: 2023
Egesta Lopci, Federica Matteucci
doaj +1 more source
Spinal decompression and radionuclide therapy for an unresectable FGF23 transmitted tumor causing cervical myelopathy: a case report and literature review. [PDF]
Yokoyama S +10 more
europepmc +1 more source
Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer. [PDF]
Hunkeler BD +5 more
europepmc +1 more source
Correction to "From Structure to Function: Zn/Mn-Modified Maghemite as an Advanced Nanoplatform for Magnetic Hyperthermia and Radionuclide Therapy". [PDF]
Ognjanović M +9 more
europepmc +1 more source
Hemodialysis-associated radioactive waste management in [131I]I and [177Lu]Lu radionuclide therapy. [PDF]
Kupitz D +4 more
europepmc +1 more source
Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. [PDF]
Yu R, Gardner L, Salavati A, Bahri S.
europepmc +1 more source
Multimodal Deep Learning for Prediction of Progression-Free Survival in Patients with Neuroendocrine Tumors Undergoing <sup>177</sup>Lu-Based Peptide Receptor Radionuclide Therapy. [PDF]
Baur S +13 more
europepmc +1 more source
Somatostatin receptor expression for peptide receptor radionuclide therapy in Japanese patients with recurrent or metastatic differentiated thyroid cancer. [PDF]
Watanabe S +7 more
europepmc +1 more source
Preclinical Lutetium-177 Intracellular Dosimetry of Target Cancers in Radionuclide Therapy. [PDF]
Lunev AS +4 more
europepmc +1 more source

